Elevated hepatic CYP2E1 content is implicated in various metabolic diseases including alcoholic liver disease, nonalcoholic fatty liver disease (NAFLD)/nonalcoholic steatohepatitis (NASH), diabetes and obesity. The gene discussed is CYP2E1; the disease is metabolic dysfunction-associated steatohepatitis.